APP and Alzheimer disease: Consistent with the reduction in the protein level of FBXL16 in the aged mouse brain tissue, stable APP-overexpressing HEK293 cells also presented a decrease in the protein level of FBXL16 (Fig. 1C), suggesting a possible protective role of FBXL16 in the regulation of AD-related disease-related proteins.